Dr.Raju'S Institute Of Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-06-2024
- Paid Up Capital ₹ 1.10 M
as on 24-06-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.47 Cr
as on 24-06-2024
- Revenue -45.80%
(FY 2021)
- Profit -13.59%
(FY 2021)
- Ebitda -24.16%
(FY 2021)
- Net Worth 13.61%
(FY 2021)
- Total Assets -0.51%
(FY 2021)
About Dr.Raju'S Institute Of Ayurveda
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹1.47 Cr.
Padma Nayani and Anandavardhana Chakrahari serve as directors at the Company.
- CIN/LLPIN
U31909TG2006PTC049370
- Company No.
049370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2006
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationA Pvt Ltd, Andhra Pradesh
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr.Raju'S Institute Of Ayurveda?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padma Nayani  | Director | 07-Nov-2013 | Current |
| Anandavardhana Chakrahari | Director | 02-Mar-2006 | Current |
Financial Performance of Dr.Raju'S Institute Of Ayurveda.
Dr.Raju'S Institute Of Ayurveda Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 45.8% decrease. The company also saw a substantial fall in profitability, with a 13.59% decrease in profit. The company's net worth Soared by an impressive increase of 13.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Raju'S Institute Of Ayurveda?
In 2021, Dr.Raju'S Institute Of Ayurveda had a promoter holding of 77.73% and a public holding of 22.27%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Techmagix It Solutions (India) Private LimitedActive 18 years 10 monthsPadma Nayani is a mutual person
Dr Raju's Ayurveda Pharmacy Private LimitedActive 7 years 4 monthsPadma Nayani and Anandavardhana Chakrahari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jul 2022 | ₹7.50 M | Open |
Others Creation Date: 12 Oct 2018 | ₹7.20 M | Open |
How Many Employees Work at Dr.Raju'S Institute Of Ayurveda?
Unlock and access historical data on people associated with Dr.Raju'S Institute Of Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Raju'S Institute Of Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Raju'S Institute Of Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
